Investor Relations

Sunshine Heart is a global medical technology company, committed to the commercialization of C-Pulse®, an implantable, non-blood contacting, heart assist therapy for the treatment of people with class III and ambulatory class IV heart failure. Sunshine Heart is listed on the NASDAQ Capital Market.

Press Releases

Posted on Aug 6, 2015
EDEN PRAIRIE, Minn., Aug. 6, 2015 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (Nasdaq:SSH) announced today that Chief Executive Officer, Dave Rosa, is scheduled to present at the 35th Annual Canaccord Genuity Growth Conference in Boston, MA on August 13th at 8:00 AM ET. About the C-Pulse® ...

Read More

Posted on Aug 4, 2015
EDEN PRAIRIE, Minn., Aug. 4, 2015 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (NASDAQ:SSH) announced today its financial results and provided a corporate update for the second quarter of 2015. The Company will host a conference call and webcast at 9:00 AM ET today to discuss its financial results and p...

Read More

Posted on Jul 30, 2015
EDEN PRAIRIE, Minn., July 30, 2015 (GLOBE NEWSWIRE) -- Sunshine Heart (NASDAQ:SSH) announced today an update on its next generation, fully implantable version of the Company's flagship C-Pulse® technology. Sunshine Heart is pleased to report that it will commence a first-in-human study using th...

Read More

Events & Presentations